V2X Misses Q2 Earnings Estimates
| AIRS Stock | USD 2.29 0.20 8.03% |
Slightly above 61% of Airsculpt Technologies' investor base is looking to short. The analysis of overall sentiment of trading Airsculpt Technologies stock suggests that many investors are alarmed at this time. Airsculpt Technologies' investing sentiment can be driven by a variety of factors including economic data, Airsculpt Technologies' earnings reports, geopolitical events, and overall market trends.
Airsculpt |
V2X delivered earnings and revenue surprises of -1.19 percent and 5.11, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock
Read at zacks.com
 |
Airsculpt Technologies Fundamental Analysis
We analyze Airsculpt Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Airsculpt Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Airsculpt Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Airsculpt Technologies is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Airsculpt Technologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Airsculpt Technologies stock to make a market-neutral strategy. Peer analysis of Airsculpt Technologies could also be used in its relative valuation, which is a method of valuing Airsculpt Technologies by comparing valuation metrics with similar companies.
Peers
Airsculpt Technologies Related Equities
| PNTG | Pennant | 2.50 | ||||
| ACHC | Acadia Healthcare | 1.55 | ||||
| EHC | Encompass Health | 0.78 | ||||
| AMED | Amedisys | 0.51 | ||||
| SEM | Select Medical | 0.41 | ||||
| UHS | Universal Health | 0.19 | ||||
| ENSG | Ensign | 0.27 | ||||
| ADUS | Addus HomeCare | 0.51 | ||||
| INNV | InnovAge Holding | 0.66 | ||||
| SGRY | Surgery Partners | 0.70 | ||||
| CCEL | CryoCell International | 1.87 | ||||
| AVAH | Aveanna Healthcare | 2.72 | ||||
| EHAB | Enhabit | 3.25 | ||||
| TOI | Oncology Institute | 8.26 |
Additional Tools for Airsculpt Stock Analysis
When running Airsculpt Technologies' price analysis, check to measure Airsculpt Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Airsculpt Technologies is operating at the current time. Most of Airsculpt Technologies' value examination focuses on studying past and present price action to predict the probability of Airsculpt Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Airsculpt Technologies' price. Additionally, you may evaluate how the addition of Airsculpt Technologies to your portfolios can decrease your overall portfolio volatility.